Exploring diversity in Non-Alcoholic Fatty Liver Disease (NAFLD) among lean, overweight, and obese patients: A Multicenter study from India
Main Article Content
Keywords
Dyslipidemia, Diabetes, NAFLD, India, Diversity, Lean
Abstract
Background: One common chronic liver illness is non-alcoholic fatty liver disease (NAFLD) affecting individuals across various body weights. Traditionally associated with obesity, NAFLD is now increasingly observed in overweight and lean individuals as well. This research investigates the clinical, metabolic, dietary pattern, and socio-demographic differences of NAFLD in lean, overweight, and obese individuals across various centers in two Indian states.
Methodology: Conducted as a cross-sectional observational study with 154 NAFLD patients aged 18-65 years across four centers [Odisha (OD) -3; Uttar Pradesh (UP) -1], the research utilized a self-administered questionnaire to gather socio-economic, biochemical, and clinical data. Data analysis involved Chi-square tests at a 0.05 significance level. Trail Registration: CTRI/2024/04/065699.
Result: The majority of NAFLD cases were found in obese patients (37.01% in Odisha and 35.06% in UP). Overweight NAFLD was more common in UP (10.39%), while lean NAFLD was more prevalent in Odisha (7.14%). Obesity was significantly associated with diabetes in both states (p=0.020). Constipation was notable in overweight and obese groups (p=0.001 and p=0.027), and bloating was more frequent in overweight individuals (p=0.064). Loss of appetite was significant among lean NAFLD patients. Biochemical parameters and food consumption across ten food groups showed no significant variation.
Conclusion: Overall, NAFLD was more common among obese patients, highlighting the need for tailored dietary interventions based on body type.
References
2. Singhai A, Yadav V, Joshi R, Malik R, T SB, Kamle S (2023) Prevalence, Metabolic Profile, and Associated Risk Factors of Non-alcoholic Fatty Liver Disease in an Adult Population of India. Cureus. https://doi.org/10.7759/cureus.33977
3. De A, Duseja A (2021) Nonalcoholic Fatty Liver Disease: Indian Perspective. Clin Liver Dis 18:158–163
4. Prasad DS, Kabir Z, Dash AK, Das BC (2012) Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res 3:204–211
5. Niriella MA, Ediriweera DS, Withanage MY, Darshika S, De Silva ST, Janaka De Silva H (2023) Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian Region: a meta-analysis. Lancet Reg Health - Southeast Asia 15:100220
6. Tan EXX, Lee JWJ, Jumat NH, et al (2022) Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study. Metabolism 126:154911
7. Wang W, Ren J, Zhou W, et al (2022) Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study. Sci Rep 12:10977
8. Chan W-K (2023) Comparison between obese and non-obese nonalcoholic fatty liver disease. Clin Mol Hepatol 29:S58–S67
9. Rahman MM, Kibria MG, Begum H, Haque M, Sultana N, Akhter M, Rowshon AHM, Ahmed F, Hasan M (2020) Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. BMJ Open Gastroenterol 7:e000535
10. K Pati G, P Singh S (2016) Nonalcoholic Fatty Liver Disease in South Asia. Euroasian J Hepato-Gastroenterol 6:154–162
11. Ye Q, Zou B, Yeo YH, et al (2020) Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 5:739–752
12. De A, Mehta M, Singh P, Bhagat N, Mitra S, Das A, Duseja A (2023) Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD. Int J Obes 47:986–992
13. Young S, Tariq R, Provenza J, Satapathy SK, Faisal K, Choudhry A, Friedman SL, Singal AK (2020) Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis. Hepatol Commun 4:953–972
14. Khayyat YM (2021) Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia. World J Hepatol 13:2150–2160
15. Nguyen VH, Ha A, Rouillard NA, et al (2023) Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol 11:1448–1454
16. Denkmayr L, Feldman A, Stechemesser L, et al (2018) Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients. J Clin Med 7:562
17. Trifan A, Rotaru A, Stafie R, et al (2022) Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease. Diagnostics 12:801
18. Wongtrakul W, Charatcharoenwitthaya N, Charatcharoenwitthaya P (2024) Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis. Ann Hepatol 29:101288
19. Kuchay MS, Martínez-Montoro JI, Choudhary NS, Fernández-García JC, Ramos-Molina B (2021) Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. Biomedicines 9:1346
20. De A, Bhagat N, Mehta M, Singh P, Rathi S, Verma N, Taneja S, Premkumar M, Duseja A (2025) Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients With Nonalcoholic Fatty Liver Disease. J Clin Exp Hepatol 15:102400
21. Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, Goel A (2022) Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis. J Clin Exp Hepatol 12:818–829
22. Sahoo PP, Singh M, Prahraj D, Yadav DP, Singh A, Uthansigh K, Pati GK (2024) Non-alcoholic fatty liver disease (NAFLD): A comparative study of clinico-socio-demographic characteristics among two diverse Indian population. Romanian Med J 71:260–266